Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biohaven Pharmaceutical Holding Co Ltd.

16.54
-1.3700-7.65%
Apr 08 16:00 EST
Volume:1.71M
Turnover:29.32M
Market Cap:1.69B
PE:-1.78
High:19.14
Open:18.95
Low:16.36
Close:17.91
1D
5D
D
W
M
Q
Y
1m
5m
10m
15m
30m
1h
2h
More
1D
5D
D
W
M
Q
Y
1m
5m
10m
15m
30m
1h
2h

Biohaven Ltd - Prepared to Commercialize Troriluzole for SCA in 2025

THOMSON REUTERS
·
11 Feb

Biohaven Announces FDA Acceptance and Priority Review of Troriluzole New Drug Application for the Treatment of Spinocerebellar Ataxia

PR Newswire
·
11 Feb

Deutsche Bank Initiates Coverage on Biohaven With Buy Rating, $65 Price Target

MT Newswires Live
·
11 Feb

Biohaven Ltd : Deutsche Bank Initiates Coverage With Buy Rating; Price Target $65

THOMSON REUTERS
·
11 Feb

Pfizer to pay ~$60M to settle Medicare false claims

TIPRANKS
·
24 Jan

Bernstein Sticks to Their Buy Rating for Biohaven Ltd. (BHVN)

TIPRANKS
·
14 Jan

Biohaven announces 2025 anticipated milestones

TIPRANKS
·
13 Jan

Biohaven enters multi-target collaboration with Merus

TIPRANKS
·
13 Jan

Merus, Biohaven Partner to Develop Bispecific Therapies for Cancers

MT Newswires Live
·
13 Jan

BRIEF-Merus And Biohaven Announce Collaboration To Co-Develop Three Novel Bispecific ADC Programs

Reuters
·
13 Jan

Biohaven - Agreement Includes Two Merus Bispecific Programs Generated Using Biclonics Platform

THOMSON REUTERS
·
13 Jan

Biohaven Ltd - Co Is Responsible for Preclinical ADC Generation of Three Merus Bispecific Antibodies Under Mutually Agreed Research Plans

THOMSON REUTERS
·
13 Jan

Biohaven Ltd - Merus Will Receive an Upfront Payment and License Fee at ADC Candidate Nomination of First Program

THOMSON REUTERS
·
13 Jan

Merus and Biohaven Announce Collaboration to Co-Develop Three Novel Bispecific ADC Programs

GlobeNewswire
·
13 Jan

Insider Buying: Biohaven Independent Director Bought US$1.0m Of Shares

Simply Wall St.
·
03 Jan

Company News for Jan 2, 2025

Zacks
·
02 Jan

Biohaven rises 6.1%

TIPRANKS
·
31 Dec 2024

Biohaven Advances in Immunotherapy: Significant IgG Reduction Achieved with BHV-1300, Gains Analyst Approval

Benzinga
·
17 Dec 2024

Biohaven Price Target Maintained With a $59.00/Share by HC Wainwright & Co.

Dow Jones
·
17 Dec 2024

Is Biohaven Ltd. (BHVN) the Best Weight Loss Stock to Buy Now According to Hedge Funds?

Insider Monkey
·
17 Dec 2024

If the download button clicks without skipping, click on the top right menu and select "Open in Browser."